Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-02 Sale | 2026-02-04 4:13 pm | Akebia Therapeutics Inc. | AKBA | Grund Nicholas Chief Commercial Officer | 84,829 | $1.39 | $117,912 | 561,750 (Direct) | View |
| 2025-02-03 Sale | 2025-02-04 5:51 pm | Akebia Therapeutics Inc. | AKBA | Grund Nicholas Chief Commercial Officer | 55,621 | $2.1 | $116,804 | 734,879 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-30 Option Award | 2026-02-03 4:42 pm | N/A 2036-01-30 | Akebia Therapeutics Inc. | AKBA | Grund Nicholas Chief Commercial Officer | 524,000 | $0 | 966,579 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-04 5:51 pm | N/A 2035-01-31 | Akebia Therapeutics Inc. | AKBA | Grund Nicholas Chief Commercial Officer | 487,200 | $0 | 734,879 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:11 pm | N/A 2034-01-31 | Akebia Therapeutics Inc. | AKBA | Grund Nicholas Chief Commercial Officer | 758,250 | $0 | 758,250 (Direct) | View |